HK1109579A1 - Pharmaceutical composition comprising drospirenone and ethynylestradiol - Google Patents

Pharmaceutical composition comprising drospirenone and ethynylestradiol

Info

Publication number
HK1109579A1
HK1109579A1 HK08100370.2A HK08100370A HK1109579A1 HK 1109579 A1 HK1109579 A1 HK 1109579A1 HK 08100370 A HK08100370 A HK 08100370A HK 1109579 A1 HK1109579 A1 HK 1109579A1
Authority
HK
Hong Kong
Prior art keywords
ethynylestradiol
drospirenone
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HK08100370.2A
Other languages
English (en)
Inventor
Carlos Ariel Sandrone
Jose Mario Sakson
Maria Del Carmen Cajarville Basaistegui
Daniel Larrosa Pomi Jose
Original Assignee
Liconsa Laboratorios Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1109579(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Laboratorios Sa filed Critical Liconsa Laboratorios Sa
Publication of HK1109579A1 publication Critical patent/HK1109579A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK08100370.2A 2004-08-09 2008-01-11 Pharmaceutical composition comprising drospirenone and ethynylestradiol HK1109579A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (fr) 2004-08-09 2004-08-09 Composition pharmaceutique contenant ethinylestradiol et drospirenone
PCT/EP2005/053759 WO2006015956A1 (fr) 2004-08-09 2005-08-02 Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol

Publications (1)

Publication Number Publication Date
HK1109579A1 true HK1109579A1 (en) 2008-06-13

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08100370.2A HK1109579A1 (en) 2004-08-09 2008-01-11 Pharmaceutical composition comprising drospirenone and ethynylestradiol

Country Status (20)

Country Link
US (1) US20090227546A1 (fr)
EP (2) EP1625849A1 (fr)
JP (1) JP2008509195A (fr)
KR (1) KR20070045247A (fr)
CN (1) CN101022811B (fr)
AR (1) AR045576A1 (fr)
AT (1) ATE464053T1 (fr)
AU (1) AU2005271206B2 (fr)
BR (1) BRPI0513938B8 (fr)
CA (1) CA2574997A1 (fr)
DE (1) DE602005020694D1 (fr)
ES (1) ES2344356T3 (fr)
HK (1) HK1109579A1 (fr)
IL (1) IL180899A0 (fr)
MA (1) MA28844B1 (fr)
NO (1) NO20071297L (fr)
RU (1) RU2007108666A (fr)
UA (1) UA87513C2 (fr)
WO (1) WO2006015956A1 (fr)
ZA (1) ZA200702038B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2531929T3 (es) * 2006-12-20 2015-03-20 Teva Women's Health, Inc. Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
HUP0700826A3 (en) * 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
WO2010114405A2 (fr) * 2009-04-01 2010-10-07 Bial - Portela & Ca., S.A. Formulations pharmaceutiques contenant des dérivés de nitrocatéchol et procédés pour les préparer
CN105878242A (zh) 2009-04-01 2016-08-24 巴尔-波特拉及康邦亚股份有限公司 包括硝基儿茶酚衍生物的药物制剂及其制备方法
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
MXPA02002043A (es) * 1999-08-31 2003-08-20 Schering Ag Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo.
EP2044941A1 (fr) * 1999-08-31 2009-04-08 Bayer Schering Pharma AG Préparation à phases multiples de drospirénone et d'estradiol comme contraceptif
DE60114467T2 (de) * 2000-12-14 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Zubereitungen enthaltend ein steroidhormon und ein stabilisierungsmittel in nicht-kristalliner form
EP1216712A1 (fr) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Complexes d'inclusion de drospirenone et de cyclodextrines

Also Published As

Publication number Publication date
IL180899A0 (en) 2007-07-04
AU2005271206A1 (en) 2006-02-16
JP2008509195A (ja) 2008-03-27
CA2574997A1 (fr) 2006-02-16
EP1848441B1 (fr) 2010-04-14
CN101022811A (zh) 2007-08-22
NO20071297L (no) 2007-05-02
WO2006015956A1 (fr) 2006-02-16
ZA200702038B (en) 2008-08-27
UA87513C2 (ru) 2009-07-27
AU2005271206B2 (en) 2009-11-26
DE602005020694D1 (de) 2010-05-27
MA28844B1 (fr) 2007-09-03
BRPI0513938B1 (pt) 2018-09-25
AR045576A1 (es) 2005-11-02
RU2007108666A (ru) 2008-09-20
ES2344356T3 (es) 2010-08-25
EP1848441A1 (fr) 2007-10-31
KR20070045247A (ko) 2007-05-02
BRPI0513938B8 (pt) 2021-05-25
ATE464053T1 (de) 2010-04-15
EP1625849A1 (fr) 2006-02-15
US20090227546A1 (en) 2009-09-10
CN101022811B (zh) 2010-09-15
BRPI0513938A (pt) 2008-05-20

Similar Documents

Publication Publication Date Title
HK1109579A1 (en) Pharmaceutical composition comprising drospirenone and ethynylestradiol
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
EP1857489A4 (fr) Microparticule et composition pharmaceutique
IL183102A0 (en) Betulin derivatives and pharmaceutical compositions containing the same
EP1863859A4 (fr) Copolymeres greffes de peg-polyacetal et de peg-polyacetal-poe et compositions pharmaceutiques
EP1890677A4 (fr) Compositions pharmaceutiques et leur utilisation
PL1894567T3 (pl) Środki farmaceutyczne do podawania skojarzonego oraz ich zastosowanie
HK1112427A1 (en) Drug delivery compositions and related methods
GB0523576D0 (en) Drug composition and its use in therapy
IL177744A0 (en) Aptamers and pharmaceutical compositions containing the same
IL178067A0 (en) Pharmaceutical dosage forms and compositions
ZA200704295B (en) Arthrospira-based compositions and uses thereof
GB0516069D0 (en) Pharmaceutical and use thereof
IL183986A0 (en) Pharmaceutical compounds and compositions
EP1765373A4 (fr) Composition pharmaceutique ozonisee et procede associe
EP1907432A4 (fr) Copolymere et composition polymerisable
IL179669A0 (en) Benzoimidazole derivatives and pharmaceutical compositions containing the same
PT1791872E (pt) Hexadecassacáridos biotinilados, composições farmacêuticas e sua utilização
IL186337A0 (en) Stannsoporfin compositions and administration
IL180316A0 (en) Quinolone-containing medicinal composition
EP1813288A4 (fr) Préparation thérapeutique, formule thérapeutique, et formule combinée
EP1937292A4 (fr) Compositions pharmaceutiques a base de lopap et leurs utilisations
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
EP1865777A4 (fr) Compositions de stannsoporfine et administration

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140802